In The News

Dr. Julie Gerberding Joins Merck Vaccines

January 25, 2010, Washington, DC: Today, Dr. Julie Gerberding takes the helm as president of Merck Vaccines. In her new role, Dr. Gerberding, who joined Accordia Global Health Foundation’s Board of Directors in 2009, will lead Merck’s vaccine operations, including introducing new vaccines and expanding access to vaccines in the developing world.

Dr. Gerberding is a long-time advocate for public health initiatives. Most recently, as director of the Centers for Disease Control and Prevention (CDC) from 2002 to 2009, she expanded the agency’s portfolio to encompass preparedness and response to bioterrorism, pandemics, and other emerging global health threats.

Reacting to the news of Dr. Gerberding’s appointment, Accordia Global Health Foundation’s president, Dr. Warner Greene, said:

“Dr. Julie Gerberding has been a leading force in the fight against infectious disease and global prevention efforts throughout her career. Her diverse work experiences and accomplishments as a public health scientist and innovator undoubtedly will be of great benefit to Merck Vaccines. Accordia congratulates Julie on her appointment and applauds Merck for their selection.”